Table 1.
Baseline characteristics of patients with high FibroScan™ values
| Feature | n = 432 |
|---|---|
| Age (years)* | 56 ± 13 (18–84) |
| Male, n (%) | 286 (66.2) |
| Aetiology (%) | |
| ALD | 35 (8.1) |
| NAFLD | 44 (10.2) |
| HBV | 27 (6.3) |
| HCV | 219 (50.7) |
| Mixed viral** | 38 (8.8) |
| Cholestatic disease | 8 (1.9) |
| Other*** | 61 (14.1) |
| Liver stiffness (kPa)* | 34.5 ± 14.6 (18–75) |
| IQR/med* | 0.21 ± 0.15 (0–1.1) |
| Success rate (%)* | 88 ± 18 (0–100) |
| Probe, n (%) | |
| S | 5 (1.1) |
| M | 356 (82.4) |
| XL | 71 (16.4) |
*Data expressed as mean ± standard deviation (range).
**Includes HIV and HDV.
***Includes multiple aetiologies, non-cirrhotic portal hypertension and other non-cirrhotic aetiologies.
Abbreviations: ALD, alcoholic liver disease; NAFLD, non-alcoholic fatty liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis D virus; IQR, interquartile range; S, small; M, medium; XL, extra-large.